Beacon Financial Group Lowered Pfizer (PFE) Position; 683 Capital Management Has Lowered By $600,000 Its Array Biopharma (ARRY) Stake

Pfizer Inc. (NYSE:PFE) Logo

Beacon Financial Group decreased Pfizer Inc (PFE) stake by 3.01% reported in 2017Q4 SEC filing. Beacon Financial Group sold 9,189 shares as Pfizer Inc (PFE)’s stock declined 3.13%. The Beacon Financial Group holds 296,186 shares with $10.73 million value, down from 305,375 last quarter. Pfizer Inc now has $217.78 billion valuation. The stock decreased 1.05% or $0.39 during the last trading session, reaching $36.61. About 26.85 million shares traded or 11.96% up from the average. Pfizer Inc. (NYSE:PFE) has risen 2.43% since May 1, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

683 Capital Management Llc decreased Array Biopharma Inc (ARRY) stake by 10% reported in 2017Q4 SEC filing. 683 Capital Management Llc sold 50,000 shares as Array Biopharma Inc (ARRY)’s stock rose 29.01%. The 683 Capital Management Llc holds 450,000 shares with $5.76M value, down from 500,000 last quarter. Array Biopharma Inc now has $2.82B valuation. The stock decreased 3.21% or $0.45 during the last trading session, reaching $13.56. About 1.75M shares traded. Array BioPharma Inc. (NASDAQ:ARRY) has risen 68.58% since May 1, 2017 and is uptrending. It has outperformed by 57.03% the S&P500.

Among 10 analysts covering Array BioPharma (NASDAQ:ARRY), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Array BioPharma has $23.0 highest and $7 lowest target. $18.14’s average target is 33.78% above currents $13.56 stock price. Array BioPharma had 37 analyst reports since June 3, 2016 according to SRatingsIntel. As per Monday, September 11, the company rating was maintained by Cantor Fitzgerald. Jefferies maintained the shares of ARRY in report on Thursday, August 24 with “Buy” rating. The rating was maintained by Cowen & Co with “Buy” on Wednesday, August 9. The rating was maintained by Jefferies on Monday, June 12 with “Buy”. Jefferies maintained it with “Buy” rating and $900 target in Thursday, July 13 report. The stock of Array BioPharma Inc. (NASDAQ:ARRY) earned “Buy” rating by Piper Jaffray on Tuesday, October 31. Stifel Nicolaus maintained it with “Buy” rating and $13 target in Friday, February 3 report. The stock of Array BioPharma Inc. (NASDAQ:ARRY) earned “Outperform” rating by Leerink Swann on Monday, January 22. Cantor Fitzgerald maintained it with “Buy” rating and $1300 target in Wednesday, August 9 report. The firm has “Buy” rating given on Friday, September 8 by Piper Jaffray.

Since December 16, 2017, it had 0 insider purchases, and 9 selling transactions for $16.27 million activity. VAN LUNSEN GIL J sold $360,340 worth of stock or 21,500 shares. The insider Haddock Jason sold $102,975. The insider Sandor Victor sold 156,016 shares worth $2.76 million. 282,874 shares were sold by Robbins Andrew R, worth $3.03 million. 819,671 shares were sold by Squarer Ron, worth $8.90 million on Saturday, December 16.

Investors sentiment increased to 1.3 in 2017 Q4. Its up 0.09, from 1.21 in 2017Q3. It increased, as 20 investors sold ARRY shares while 50 reduced holdings. 27 funds opened positions while 64 raised stakes. 194.11 million shares or 1.73% more from 190.80 million shares in 2017Q3 were reported. Parallax Volatility Advisers Limited Partnership has invested 0% in Array BioPharma Inc. (NASDAQ:ARRY). 79,803 are owned by Landscape Cap Lc. Jacobs Levy Equity Mgmt holds 0.01% in Array BioPharma Inc. (NASDAQ:ARRY) or 49,860 shares. Endurant Cap Management Limited Partnership has 50,600 shares for 0.2% of their portfolio. State Of Wisconsin Inv Board invested in 169,100 shares. State Of New Jersey Common Pension Fund D has invested 0.01% of its portfolio in Array BioPharma Inc. (NASDAQ:ARRY). Citadel Advisors Lc holds 1.35 million shares. Weiss Multi stated it has 175,000 shares. The Georgia-based Voya Invest Mngmt Ltd has invested 0% in Array BioPharma Inc. (NASDAQ:ARRY). Panagora Asset Mgmt holds 0.06% or 1.18 million shares in its portfolio. Amalgamated Savings Bank invested in 0.01% or 27,101 shares. Price T Rowe Associates Inc Md owns 3.58 million shares or 0.01% of their US portfolio. Blackrock owns 15.25M shares for 0.01% of their portfolio. The Netherlands-based Shell Asset Mgmt has invested 0.01% in Array BioPharma Inc. (NASDAQ:ARRY). Polar Capital Llp reported 250,000 shares.

Analysts await Array BioPharma Inc. (NASDAQ:ARRY) to report earnings on May, 9. They expect $-0.22 EPS, down 4.76% or $0.01 from last year’s $-0.21 per share. After $-0.17 actual EPS reported by Array BioPharma Inc. for the previous quarter, Wall Street now forecasts 29.41% negative EPS growth.

683 Capital Management Llc increased Trivago N V stake by 2.02 million shares to 2.32M valued at $15.86 million in 2017Q4. It also upped Coca Cola Co (Put) (NYSE:KO) stake by 637,500 shares and now owns 1.14M shares. Tracon Pharmaceuticals Inc was raised too.

Beacon Financial Group increased Exxon Mobil Corporation (NYSE:XOM) stake by 24,119 shares to 209,841 valued at $17.55 million in 2017Q4. It also upped Cvs Caremark Corporation (NYSE:CVS) stake by 62,765 shares and now owns 126,945 shares. Wisdomtree Tr (DON) was raised too.

Investors sentiment increased to 1.06 in Q4 2017. Its up 0.10, from 0.96 in 2017Q3. It is positive, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds opened positions while 632 raised stakes. 4.07 billion shares or 0.28% more from 4.06 billion shares in 2017Q3 were reported. Sg Americas Securities Llc has invested 0.4% in Pfizer Inc. (NYSE:PFE). Family Cap Trust has 0.12% invested in Pfizer Inc. (NYSE:PFE). 250,400 are owned by Laurion Cap Mngmt Limited Partnership. Archon Prtn Limited Liability Corporation owns 2.5% invested in Pfizer Inc. (NYSE:PFE) for 317,000 shares. Moreover, Umb Bancshares N A Mo has 0.42% invested in Pfizer Inc. (NYSE:PFE) for 355,363 shares. Pinnacle Wealth Advisory Gru Limited Co has 36,009 shares for 0.72% of their portfolio. Wendell David Assoc holds 0.36% or 58,713 shares in its portfolio. Miracle Mile Advsr Llc stated it has 0.05% in Pfizer Inc. (NYSE:PFE). Rocky Mountain Advisers Lc stated it has 118 shares or 0.02% of all its holdings. Hap Trading Limited Com has invested 0.03% in Pfizer Inc. (NYSE:PFE). Qci Asset Mngmt Inc holds 0.02% or 5,002 shares. Sns Fincl Group Limited Company has 1.16% invested in Pfizer Inc. (NYSE:PFE) for 133,027 shares. Davenport And Ltd Com owns 255,613 shares for 0.11% of their portfolio. Timber Hill accumulated 164,405 shares. Df Dent Com Inc has invested 0.04% of its portfolio in Pfizer Inc. (NYSE:PFE).

Among 22 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 12 Hold. Therefore 41% are positive. Pfizer has $54.0 highest and $33.0 lowest target. $39.75’s average target is 8.58% above currents $36.61 stock price. Pfizer had 78 analyst reports since July 29, 2015 according to SRatingsIntel. On Monday, May 2 the stock rating was maintained by Leerink Swann with “Market Perform”. The stock of Pfizer Inc. (NYSE:PFE) has “Outperform” rating given on Thursday, October 19 by BMO Capital Markets. On Friday, August 28 the stock rating was maintained by Piper Jaffray with “Overweight”. The stock has “Buy” rating by BMO Capital Markets on Tuesday, September 5. As per Tuesday, January 16, the company rating was maintained by Jefferies. Jefferies maintained the stock with “Hold” rating in Friday, April 13 report. The company was initiated on Tuesday, December 1 by Barclays Capital. As per Tuesday, November 29, the company rating was upgraded by Barclays Capital. On Wednesday, November 2 the stock rating was downgraded by Argus Research to “Hold”. The firm earned “Hold” rating on Thursday, May 12 by Berenberg.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart